World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00443079
Date of registration: 02/03/2007
Primary sponsor: University of California, San Diego
Public title: A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)
Scientific title: A Single-center, Single-blinded, Placebo-controlled Pilot Study of IdB 1016 (Siliphos) in Adult Patients With Non-alcoholic Steatohepatitis (NASH)
Date of first enrolment: March 2007
Target sample size: 10
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00443079
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Heather M Patton, MD
Address: 
Telephone:
Email:
Affiliation:  University of California, San Diego
Key inclusion & exclusion criteria

Inclusion Criteria:

- Liver biopsy within 12 months demonstrating NASH

- Abnormal ALT

Exclusion Criteria:

- Uncontrolled diabetes

- Hepatitis B, hepatitis C, or other chronic liver conditions

- Abnormal kidney function

- Excess alcohol consumption



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Fatty Liver
Intervention(s)
Drug: IdB 1016 (Siliphos)
Primary Outcome(s)
Safety, as determined by laboratory and clinical assessment, during and after treatment [Time Frame: 4 months]
Tolerability, as determined by clinical assessment of side effects, during and after treatment [Time Frame: 4 months]
Secondary Outcome(s)
Efficacy, determined by serial measurement of serum aminotransferase levels before, during, and after treatment [Time Frame: 4 months]
Secondary ID(s)
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history